Myung In Pharm Attracts 17.36 Trillion Won in Subscription Deposits—IPO Oversubscribed 587 - 1
Myung In Pharm Co. drew 17.36 trillion won ($13.1 billion) in retail IPO deposits, with subscriptions oversubscribed 587:1, reflecting strong investor demand and market confidence.
Myung In Pharm set its IPO price at the top of its range at 58,000 won per share, raising 197.2 billion won and valuing the company at 846.8 billion won, after strong demand from institutional investors and a high lock-up commitment rate.
#YonhapInfomax #MyungInPharm #IPO #KOSPI #InstitutionalInvestors #MarketCapitalization #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=82124
Myung In Pharm Sets IPO Price at Top End of Range at 58,000 Won, Valuing Company at 850 Billion Won
Myung In Pharm set its IPO price at the top of its range at 58,000 won per share, raising 197.2 billion won and valuing the company at 846.8 billion won, after strong demand from institutional investors and a high lock-up commitment rate.
Myungin Pharm is set to price its KOSPI IPO at the top of its range, driven by strong institutional demand and robust financials, with proceeds earmarked for business expansion and R&D.
#YonhapInfomax #MyunginPharm #KOSPIIPO #OperatingMargin #InstitutionalDemand #KB Securities
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=81775
Myungin Pharm Set for KOSPI Debut with IPO Price Likely at Upper End
Myungin Pharm is set to price its KOSPI IPO at the top of its range, driven by strong institutional demand and robust financials, with proceeds earmarked for business expansion and R&D.
S2W, a security-focused AI firm, will debut on KOSDAQ under new IPO rules, while Myungin Pharm opens KOSPI subscription; both highlight South Korea’s evolving capital markets.
#YonhapInfomax #S2W #KOSDAQ #IPO #MyunginPharm #AI #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=81604S2W, a South Korean AI and big data firm, opens retail IPO subscription this week, while Myungin Pharm and Nota launch institutional bookbuilding for upcoming KOSPI and KOSDAQ listings, respectively.
#YonhapInfomax #S2W #IPO #MyunginPharm #Nota #Bookbuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=80497
This Week - S2W IPO Subscription Opens—Myungin Pharm and Nota Launch Institutional Bookbuilding
S2W, a South Korean AI and big data firm, opens retail IPO subscription this week, while Myungin Pharm and Nota launch institutional bookbuilding for upcoming KOSPI and KOSDAQ listings, respectively.
Yonhap Infomax News